Distribution of 26RFa binding sites and GPR103 mRNA in the central nervous system of the rat. 2007

Federica Bruzzone, and Benoît Lectez, and David Alexandre, and Sylvie Jégou, and Lourdes Mounien, and Hélène Tollemer, and David Chatenet, and Jérôme Leprince, and Mauro Vallarino, and Hubert Vaudry, and Nicolas Chartrel
Institut National de la Santé et de la Recherche Médicale U 413, Laboratory of Cellular and Molecular Neuroendocrinology, European Institute for Peptide Research (IFRMP 23), University of Rouen, 76821 Mont-Saint-Aignan, France.

The novel RFamide peptide 26RFa, the endogenous ligand of the orphan receptor GPR103, affects food intake, locomotion, and activity of the gonadotropic axis. However, little is known regarding the localization of 26RFa receptors. The present report provides the first detailed mapping of 26RFa binding sites and GPR103 mRNA in the rat central nervous system (CNS). 26RFa binding sites were widely distributed in the brain and spinal cord, whereas the expression of GPR103 mRNA was more discrete, notably in the midbrain, the pons, and the medulla oblongata, suggesting that 26RFa can bind to a receptor(s) other than GPR103. Competition experiments confirmed that 26RFa interacts with an RFamide peptide receptor distinct from GPR103 that may be NPFF2. High densities of 26RFa binding sites were observed in olfactory, hypothalamic, and brainstem nuclei involved in the control of feeding behavior, including the piriform cortex, the ventromedial and dorsomedial hypothalamic nuclei, the paraventricular nucleus, the arcuate nucleus, the lateral hypothalamic area, and the nucleus of the solitary tract. The preoptic and anterior hypothalamic areas were also enriched with 26RFa recognition sites, supporting a physiological role of the neuropeptide in the regulation of the gonadotropic axis. A high density of 26RFa binding sites was detected in regions of the CNS involved in the processing of pain, such as the dorsal horn of the spinal cord and the parafascicular thalamic nucleus. The wide distribution of 26RFa binding sites suggests that 26RFa has multiple functions in the CNS that are mediated by at least two distinct receptors.

UI MeSH Term Description Entries
D007456 Iodine Isotopes Stable iodine atoms that have the same atomic number as the element iodine, but differ in atomic weight. I-127 is the only naturally occurring stable iodine isotope. Isotopes, Iodine
D008297 Male Males
D009479 Neuropeptides Peptides released by NEURONS as intercellular messengers. Many neuropeptides are also hormones released by non-neuronal cells. Neuropeptide
D011869 Radioligand Assay Quantitative determination of receptor (binding) proteins in body fluids or tissue using radioactively labeled binding reagents (e.g., antibodies, intracellular receptors, plasma binders). Protein-Binding Radioassay,Radioreceptor Assay,Assay, Radioligand,Assay, Radioreceptor,Assays, Radioligand,Assays, Radioreceptor,Protein Binding Radioassay,Protein-Binding Radioassays,Radioassay, Protein-Binding,Radioassays, Protein-Binding,Radioligand Assays,Radioreceptor Assays
D001931 Brain Mapping Imaging techniques used to colocalize sites of brain functions or physiological activity with brain structures. Brain Electrical Activity Mapping,Functional Cerebral Localization,Topographic Brain Mapping,Brain Mapping, Topographic,Functional Cerebral Localizations,Mapping, Brain,Mapping, Topographic Brain
D002490 Central Nervous System The main information-processing organs of the nervous system, consisting of the brain, spinal cord, and meninges. Cerebrospinal Axis,Axi, Cerebrospinal,Axis, Cerebrospinal,Central Nervous Systems,Cerebrospinal Axi,Nervous System, Central,Nervous Systems, Central,Systems, Central Nervous
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D001667 Binding, Competitive The interaction of two or more substrates or ligands with the same binding site. The displacement of one by the other is used in quantitative and selective affinity measurements. Competitive Binding

Related Publications

Federica Bruzzone, and Benoît Lectez, and David Alexandre, and Sylvie Jégou, and Lourdes Mounien, and Hélène Tollemer, and David Chatenet, and Jérôme Leprince, and Mauro Vallarino, and Hubert Vaudry, and Nicolas Chartrel
January 1986, Peptides,
Federica Bruzzone, and Benoît Lectez, and David Alexandre, and Sylvie Jégou, and Lourdes Mounien, and Hélène Tollemer, and David Chatenet, and Jérôme Leprince, and Mauro Vallarino, and Hubert Vaudry, and Nicolas Chartrel
June 1988, Brain research,
Federica Bruzzone, and Benoît Lectez, and David Alexandre, and Sylvie Jégou, and Lourdes Mounien, and Hélène Tollemer, and David Chatenet, and Jérôme Leprince, and Mauro Vallarino, and Hubert Vaudry, and Nicolas Chartrel
August 1999, The Journal of comparative neurology,
Federica Bruzzone, and Benoît Lectez, and David Alexandre, and Sylvie Jégou, and Lourdes Mounien, and Hélène Tollemer, and David Chatenet, and Jérôme Leprince, and Mauro Vallarino, and Hubert Vaudry, and Nicolas Chartrel
January 1998, Progress in brain research,
Federica Bruzzone, and Benoît Lectez, and David Alexandre, and Sylvie Jégou, and Lourdes Mounien, and Hélène Tollemer, and David Chatenet, and Jérôme Leprince, and Mauro Vallarino, and Hubert Vaudry, and Nicolas Chartrel
August 1984, The Journal of neuroscience : the official journal of the Society for Neuroscience,
Federica Bruzzone, and Benoît Lectez, and David Alexandre, and Sylvie Jégou, and Lourdes Mounien, and Hélène Tollemer, and David Chatenet, and Jérôme Leprince, and Mauro Vallarino, and Hubert Vaudry, and Nicolas Chartrel
March 1986, European journal of pharmacology,
Federica Bruzzone, and Benoît Lectez, and David Alexandre, and Sylvie Jégou, and Lourdes Mounien, and Hélène Tollemer, and David Chatenet, and Jérôme Leprince, and Mauro Vallarino, and Hubert Vaudry, and Nicolas Chartrel
November 1986, Brain research,
Federica Bruzzone, and Benoît Lectez, and David Alexandre, and Sylvie Jégou, and Lourdes Mounien, and Hélène Tollemer, and David Chatenet, and Jérôme Leprince, and Mauro Vallarino, and Hubert Vaudry, and Nicolas Chartrel
November 1999, FEBS letters,
Federica Bruzzone, and Benoît Lectez, and David Alexandre, and Sylvie Jégou, and Lourdes Mounien, and Hélène Tollemer, and David Chatenet, and Jérôme Leprince, and Mauro Vallarino, and Hubert Vaudry, and Nicolas Chartrel
June 2014, Journal of molecular endocrinology,
Federica Bruzzone, and Benoît Lectez, and David Alexandre, and Sylvie Jégou, and Lourdes Mounien, and Hélène Tollemer, and David Chatenet, and Jérôme Leprince, and Mauro Vallarino, and Hubert Vaudry, and Nicolas Chartrel
January 1978, Toxicon : official journal of the International Society on Toxinology,
Copied contents to your clipboard!